ural measles virus infection results in lifelong immunity, a large majority of persons aged 115 years should be immune to measles [6] . Therefore, the PAHO recommends a strategy that seeks to rapidly interrupt the transmission of measles by means of an initial mass vaccination campaign ("catch-up") for all children aged 9 months to 14 years. The interruption of transmission is maintained through a high degree of population immunity provided by vaccination of children aged у12 months in the routine vaccination services ("keep-up"), complemented by periodic mass vaccination campaigns every 4 years ("follow-up"), targeting all children aged 1-4 years, regardless of previous vaccination status. The aim of this second vaccination opportunity is, first and foremost, to deliver the first dose to those children who never received any measles vaccination, and to deliver a second dose to all children who previously received a first dose, thus reaching those who had a primary vaccine failure. The most effective strategy to reach 95% vaccination during follow-up campaigns is nationwide house-to-house vaccination. In rural areas with disperse populations, vaccination teams can either vaccinate house to house or set up temporary vaccination posts in central places. When temporary vaccination posts are used, families are called to the post by volunteers or assistants with loudspeakers who walk throughout the area announcing the campaign. Until 1995, the PAHO recommended routine keep-up vaccination of children at age 9 months. Since 1996, however, the recommended age at vaccination is 12 months. The rationale for this change is 2-fold: the immune response to a vaccine administered at age 12 months is better than at age 9 months, and with improved measles control by 1996, it was possible to delay recommended vaccination until age 12 months because the risk of exposure before 12 months of age had been reduced significantly [7] [8] [9] .
The initial catch-up measles vaccination campaign should be done during a period of low transmission. All children aged 9 months to 14 years, regardless of previous vaccination status or reported history of measles, receive 1 dose of measles vaccine during a short period of time, usually from a week to a month. These campaigns lead to a rapid increase in population immunity, and if they achieve a sufficiently high coverage, measles transmission is interrupted. An evaluation of the catch-up campaign should be implemented and, if any groups of susceptible children are identified, special "mop-up" vaccination campaigns should be conducted in those areas to increase coverage.
After the initial catch-up campaign, routine keep-up vaccination services should ensure that all birth cohorts receive a dose of a measles-containing vaccine at 12 months of age. Two main factors contribute to an inevitable accumulation of susceptible preschool children. First, the measles vaccine is not 100% effective; therefore, some children are not protected after their first dose despite being vaccinated. Second, measles vaccine coverage never reaches 100%, even for the most effective vaccination programs.
Consequently, the PAHO strategy includes periodic follow-up vaccination campaigns for preschool children, recommended at an interval when the estimated number of susceptible persons approaches the size of an average annual birth cohort. In the Americas, these follow-up campaigns are recommended every 4 years and should be targeted to all children aged 1-4 years regardless of their prior vaccination status. The follow-up campaigns should be closely monitored through the analysis of coverage data, strong field supervision, and rapid house-tohouse monitoring to verify that children have been vaccinated, and if any groups of susceptible children are identified, special mop-up vaccination campaigns should be conducted in those areas to increase coverage [10] .
A sensitive surveillance system, in which all suspected cases are reported and investigated in a timely fashion, is indispensable for the measles eradication program. Confirmation of measles should be based on serological evidence or an epidemiological link with a laboratory-confirmed case. Determining the genome of the measles virus isolated from patients facilitates the identification of the geographic sources of the outbreaks and helps trace the chains of transmission. Since 1991, all PAHO  member countries, except the United States and Canada, have  conducted catch-up campaigns against measles (table 1) , and the majority have had at least 1 follow-up campaign. Also, in 1994, Canada conducted a nationwide vaccination campaign for administering a second dose of measles-containing vaccine to all school students up to at least grade 12.
RESULTS

Application of the PAHO strategy.
First countries to interrupt transmission. Several countries have already interrupted measles transmission for many years. In Cuba, where the catch-up campaign took place in 1987 and a follow-up campaign was implemented in 1991, the last serologically confirmed case occurred in June 1993 [5] . Transmission also appears to have been interrupted in the English-speaking Caribbean countries, which conducted catch-up measles vaccination campaigns in May 1991. After the campaigns, no measles cases were confirmed through 1996. In 1997, 2 laboratoryconfirmed cases were reported. The first, from the Bahamas, was in a young adult who presented with exanthema in March 1997. It was not possible to identify the source of transmission, but it is suspected that the patient was infected through contact with an infected tourist. A nationwide case search was implemented to detect secondary cases. No additional cases were found after a review of medical records of 180,000 patients [11] . The second case was reported by Trinidad and Tobago in a young adult who presented with exanthema in April 1997. The patient, an Italian seaman, had contracted measles in Italy.
In Chile, after the catch-up campaign in 1992, one case, imported from Peru, occurred in 1992 and another, imported from Venezuela, in 1993. No secondary spread was reported after either of these cases. Thirty confirmed cases resulted from an importation from Brazil in 1997, and 31 confirmed cases occurred after an importation from Argentina in 1999. No confirmed cases have been reported since then. In Uruguay, the last outbreaks occurred during September 1998-February 1999, after 4 different importations from Argentina (table 2). In this outbreak, unvaccinated health care workers and exposure in health care settings substantially contributed to disease transmission. No other cases have been reported since then. Also, Canada and, since 1997, the United States, have reported no indigenous transmission [12] .
Measles, 1996-2001. The number of confirmed cases registered in the Americas in 1996 (2109) was the lowest since surveillance started (figure 1). However, in 1997, a major resurgence of measles occurred in Brazil. A total of 53,661 confirmed cases were reported in the region of the Americas in 1997; of these, 52,284 (97%) were reported from Brazil. Other countries that reported measles cases in 1997 included Canada (579), the United States (138), Argentina (125), Paraguay (121), Guadeloupe (116), Chile (58), and Costa Rica (26). Outbreaks in Argentina, Chile, Costa Rica, and Paraguay resulted from imported cases from Brazil. The Guadeloupe outbreak was traced to a case imported from France in the end of 1996 [11] . Most cases in the region were reported from São Paulo, the only state that did not implement the recommended followup campaign in 1995. Almost 48,000 cases were reported in the city of São Paulo, 150% of them among young adults aged 20-29 years. Incidence was highest among infants, young adults aged 20-29, and children aged 1-4 years. More than 50 deaths were reported, mostly among children !1 year of age. A casecontrol study performed during the outbreak identified migrants from rural areas as a high-risk group for measles virus infection [13] . Many of them came to the city of São Paulo to work in the construction business. Other high-risk groups included students, health care workers, employees of the tourist industry, and military recruits. The outbreak was brought under control after an energetic response that included a follow-up vaccination campaign, selective vaccination in schools, and vaccination of young adults at high risk. The following year, São Paulo reported only 268 confirmed measles cases.
In the United States, more than half of the cases reported in 1997 stemmed from imports from Europe and Asia. Secondary spread from these imported cases was limited. The largest outbreak in the United States in 1997 consisted of only 8 cases. Five confirmed cases were imported into the United States from Brazil (figure 2). In the 2 preceding years, no measles cases had been imported into the United States from Latin America or the Caribbean ( figure 3 ).
During 1998, countries of the Americas reported 14,488 confirmed measles cases and 56 deaths (figure 1). The largest outbreak occurred in Argentina, with 10,229 confirmed cases. Although according to PAHO's guidelines Argentina should have implemented a follow-up campaign in 1997, this was not done. The outbreak started after importations from São Paulo. Among cases in Argentina, 6551 (64%) were from Buenos Aires Province. Of these, 65% occurred in infants and children aged !5 years, most of whom were unvaccinated. Cases decreased after a 1998 follow-up vaccination campaign that reportedly achieved 98% coverage. Other countries that reported relatively large numbers of cases in 1998 include Brazil (2930 cases), Bolivia (1004), the United States (100), Paraguay (70), Colombia (61), and the Dominican Republic (25) (table 2). The US cases that were genetically analyzed were importation-related [12] .
In 1999, there were 3209 confirmed cases reported from 11 countries, 78% fewer than in 1998 (table 2) . Canada, Chile, Costa Rica, Peru, Uruguay, and the United States reported measles importations in 1999 with limited spread because of high vaccination coverage. Indigenous transmission occurred in 4 countries: Bolivia (1441 cases), which had the largest outbreak, Brazil (908), Argentina (313), and the Dominican Republic (274) (table 2). In total, 44 and 12 sporadic cases were reported from Colombia and Venezuela, respectively, but no virological specimens were available and no secondary transmission was identified after repeated active search attempts. The Bolivia epidemic began in May 1998 in Yacuiba, bordering Argentina, and spread to all departments in a succession of outbreaks that continued over a period of 2.5 years. The total number of confirmed cases during this outbreak was 2567 (32 cases/100,000 population), with 4 deaths. Of the total cases, 80% occurred in Santa Cruz, Cochabamba, and La Paz, the country's most populated departments with the largest urban centers, which receive the highest immigration from rural areas. Most case patients (91%) had no history of prior vaccination. The highest incidence (209/100,000) was in children aged 6- (6) (table 2). Also, Colombia and Peru reported 1 case each confirmed by serological testing, but no virological specimens were available and no secondary transmission was identified. The largest outbreak occurred in Haiti, where routine measles immunization coverage has been low for many years, averaging 47% (range, 32%-85%) during 1995-1999. A follow-up vaccination campaign was conducted in 1999, but coverage was low (70%-80%). The outbreak began in March 2000, in Artibonite, most likely because of importation from the Dominican Republic. The total number of cases for 2000 was 990 (57% of the region's total). Most cases occurred among unvaccinated children aged !5 years.
Three countries with high vaccination coverage. Canada, Mexico, and the United States reported measles importations with limited secondary spread. The largest of these importation-related outbreaks (165 cases) occurred in Canada among groups opposed to vaccination. The index case patient was a Canadian citizen who was infected during a visit to a Mennonite community in Bolivia.
During June 2001, a total of 539 cases have been reported in the region, the lowest number ever recorded. Indigenous transmission occurred in 3 countries: Haiti (159 cases), Venezuela (115), and the Dominican Republic (113) (table 2). Also, Colombia (1) and Ecuador (2) reported cases confirmed by serological testing, but no virological specimens were available and no secondary transmission was identified (table 2) . Brazil, Canada, El Salvador, Mexico, and the United States reported measles importations with no or limited spread because of high vaccination coverage.
The Haiti outbreak (which had started in 2000) ended in September 2001, after a nationwide house-to-house follow-up campaign that reportedly achieved 100% coverage. Coverage among children interviewed in all municipalities during rapid house-to-house monitoring was ∼90%.The Dominican Republic outbreak, which had started in 1999, was the second largest in 2001 (113 cases, 19% of the region's total). The highest incidence during the outbreak was among infants aged !9 months (14 cases/100,000), children aged 9 months to 4 years (5/100,000), and adults aged 20-29 years (3/100,000). Outbreak investigations indicated that most cases in adults occurred among young factory workers in large cities that attract migrants from rural areas. A follow-up vaccination campaign, Measles virus genotypes. Since December 1997, virus isolates were obtained from 10 outbreaks in the region (including urine specimens from Argentina, Brazil, Bolivia, Chile, Dominican Republic, Haiti, Uruguay, and Venezuela) and were analyzed by the measles laboratories of the Centers for Disease Control and Prevention and Fundação Oswaldo Cruz in Brazil. The viruses from all except the Venezuela outbreak were of genotype D6, which indicates its continued indigenous circulation in the region. Specimens obtained from the outbreak in Venezuela were preliminarily identified as genotype D9.
DISCUSSION
The extraordinary progress of the region of the Americas in its fight against measles since the 1994 PAHO goal of interrupting indigenous measles transmission shows that transmission can be interrupted and that this can be sustained over a long period of time if countries fully apply the PAHO's vaccination strategy. The dramatic decrease in the contribution of Latin American cases to measles importations into the United States since the beginning of the PAHO initiative is further evidence that the sustainable interruption of measles transmission is reachable ( figure 3) .
As the measles virus continues to circulate in other parts of the world, the Americas will continue to be at risk for measles importations. Improved measles control and the interruption of indigenous transmission in other regions of the world, especially Europe and Asia, with the final target to eradicate measles throughout the world will lessen and ultimately remove this risk.
A recent evaluation of the cost-effectiveness of the PAHO's efforts to interrupt indigenous measles transmission has shown that the PAHO's overall strategy prevents a single case of measles at the cost of US$72 and prevents a death because of measles at the cost of US$15,000, thus saving a total of US$208 million in treatment costs because of reduced incidence of measles [14] .
Although the 1997 measles resurgence in the Americas represents an important increase compared with the number of cases reported in 1996, the total of 53,661 represents only ∼22% of the cases reported in the region in 1990. Contributing factors for the 1997 resurgence included the following: first, the lack of a timely follow-up measles vaccination campaign in São Paulo in 1995 combined with low routine vaccination coverage with at least 1 dose of measles vaccine, which permitted the rapid accumulation of susceptible children; second, the presence of a great number of young adults who had never been vaccinated or exposed to natural measles virus infection, which increased the pool of susceptible persons; and finally, São Paulo's high population density, which facilitated contact between susceptible and infected persons.
Measles surveillance data, combined with the results of molecular epidemiology studies, indicate that the countries of the Americas are exposed continually to measles virus from other regions of the world where measles continues to be endemic [13] . Twenty-three importations of measles viruses from Europe, 17 from Asia, and 2 from Africa were detected in several countries of the region in 1997 ( figure 2) . However, these data may largely underestimate the true number of measles importations; many imported cases may go undetected because the patient may receive no medical care or cause no secondary transmission.
The outbreaks in Argentina, Bolivia, Brazil, Canada, the Dominican Republic, and Venezuela indicate that many young adults may remain susceptible to measles. However, for practical reasons, it can be assumed that most persons born before 1960 in most countries of the Americas were exposed to measles and, as a result, are immune. Although systematic mass vaccination of young adults is not recommended, depending on the country's epidemiology, consideration should be given to vaccination of some young adults, including groups philosophically opposed to vaccination; military recruits; university students; persons living or working in crowded environments, including prisons and large factories; and young adults of rural origin, including migrant workers, who may be less likely to have been vaccinated or exposed to natural measles. Also, young adults in frequent contact with susceptible persons, particularly health care workers, should be vaccinated. In addition, adolescents and young adults who travel to countries where transmission of measles is endemic run greater risk of exposure to measles.
RECOMMENDATIONS
The PAHO recommends the following strategies to achieve, maintain, and monitor the interruption of indigenous measles transmission in the region.
Obtain 195% routine coverage with measles-containing vaccine in all municipalities. Countries should validate coverage regularly through rapid house-to-house monitoring [10] and by comparing the number of first doses of measles vaccine administered with the number of first doses of diphtheria-tetanuspertussis vaccine or the number of doses of bacille CalmetteGuérin vaccine.
Perform follow-up campaigns at least every 4 years, achieving 95% vaccination coverage in all municipalities. Supervisors should verify daily the vaccination effort during campaigns through rapid house-to-house monitoring.
Vaccinate and monitor coverage among groups at high risk for acquiring or transmitting the disease. These include health care workers and some groups of young adults.
Conduct reliable routine surveillance. Supervisors should actively validate surveillance data by searching for cases during all house-to-house vaccinations, by regular visits to schools and health care centers, and by regular visits to high-risk areas (e.g., those where coverage is low, that do not submit weekly reports, with limited access to health services, where tourism or immigration are high, or that have had cases during the preceding weeks).
Investigate all cases and outbreaks. This includes conducting household visits within 48 h of identifying a suspected case and investigating all contacts and settings visited by the case patient during both the exposure (7-18 days preceding rash onset) and infectious periods (from the first respiratory symptoms until 4 days after rash onset); collecting blood and either throat or nasopharyngeal swabs or urine specimens at first contact with the suspected case patient and sending them to the country's measles reference laboratory within 5 days of taking them (the laboratory should report serological results within 4 days); and evaluating the risk factors involved in each outbreak, their link to importations, and the viral genotypes involved.
